Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.80T | 2.54T | 1.21T | 1.02T | 936.66B | 791.75B | Gross Profit |
2.80T | 2.54T | 1.21T | 1.02T | 936.66B | 791.75B | EBIT |
1.67T | 1.02T | 661.56B | 518.56B | 439.80B | 365.75B | EBITDA |
501.01B | 1.05T | 0.00 | 0.00 | 0.00 | 0.00 | Net Income Common Stockholders |
695.80B | 640.62B | 495.45B | 386.00B | 325.98B | 260.27B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
7.24T | 2.29T | 7.24T | 5.99T | 5.32T | 4.13T | Total Assets |
25.76T | 44.12T | 25.76T | 21.11T | 17.98T | 15.96T | Total Debt |
3.24T | 7.31T | 3.24T | 2.19T | 1.48T | 1.47T | Net Debt |
878.07B | 5.02T | 878.07B | 587.42B | 443.06B | 742.81B | Total Liabilities |
22.84T | 36.23T | 22.84T | 18.60T | 15.82T | 14.07T | Stockholders Equity |
2.91T | 4.56T | 2.91T | 2.50T | 2.16T | 1.89T |
Cash Flow | Free Cash Flow | ||||
0.00 | 147.83B | 433.58B | 554.69B | 903.97B | 152.89B | Operating Cash Flow |
0.00 | 190.69B | 477.20B | 581.02B | 921.78B | 171.18B | Investing Cash Flow |
0.00 | 53.14B | -4.39T | -3.30T | -2.52T | -2.15T | Financing Cash Flow |
0.00 | 3.35T | 4.17T | 2.91T | 1.92T | 1.85T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $109.88B | 18.86 | 18.52% | 0.64% | 24.97% | 13.74% | |
75 Outperform | $77.28B | 23.59 | 33.16% | 2.20% | 3.08% | 11.92% | |
73 Outperform | $162.30B | 20.11 | 14.96% | 0.90% | 37.85% | 0.54% | |
68 Neutral | $32.56B | 29.32 | 16.59% | 1.98% | -3.41% | 67.87% | |
64 Neutral | $14.53B | 10.25 | 8.67% | 4.22% | 16.51% | -12.20% | |
43 Neutral | $3.67M | ― | -178.85% | ― | 2.35% | 80.94% |